Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041041
Filing Date
2023-11-14
Accepted
2023-11-14 16:05:38
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1335644
2 ex31-1.htm EX-31.1 12477
3 ex32-1.htm EX-32.1 7891
  Complete submission text file 0001493152-23-041041.txt   6311348

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE plsh-20230930.xsd EX-101.SCH 46121
5 XBRL CALCULATION FILE plsh-20230930_cal.xml EX-101.CAL 58114
6 XBRL DEFINITION FILE plsh-20230930_def.xml EX-101.DEF 202293
7 XBRL LABEL FILE plsh-20230930_lab.xml EX-101.LAB 382024
8 XBRL PRESENTATION FILE plsh-20230930_pre.xml EX-101.PRE 311766
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 962979
Mailing Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121
Business Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121 561-455-4822
PANACEA LIFE SCIENCES HOLDINGS, INC. (Filer) CIK: 0001552189 (see all company filings)

EIN.: 271085858 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38190 | Film No.: 231405910
SIC: 2833 Medicinal Chemicals & Botanical Products